Total Funding
57
36
Total FundingPost-IPO Equity raised
Growth Score
-12 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
138884
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.
Chaim Lotan: CMOPast Role: Hadassah Medical Center, Head
David Blossom: VP of Global Marketing & StrategyPast Role: Boston Scientific, Sales Leadership Roles
About the Company
InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. The company applies its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD’s mission is to utilize its proprietary technology to make its products the
industry standard for stents and to provide a solution to the key clinical issues of current stenting: embolic showers, restenosis, and late stent thrombosis.
